FMT in Gut aGVHD Treated
Recruiting
- Conditions
- Acute-graft-versus-host Disease
- Registration Number
- NCT03148743
- Brief Summary
With the stem cell transplanting increasing, patients which effected with gut GVHD were also increased. To evaluation the safety and efficacy of FMT for gut GVHD,patients with gut GVHD were recruited.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- gut GVHD
Exclusion Criteria
- Age>60; or Age<10
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method times of stool 24hours,48hours,72hours, 96hours,fifth day,sixth day, a week Change from stool times in a week
- Secondary Outcome Measures
Name Time Method volume in milliliter of stool 24hours,48hours,72hours, 96hours,fifth day,sixth day, a week Change from stool volume in a week
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie FMT efficacy in gut aGVHD post-stem cell transplant?
How does FMT compare to corticosteroids in treating gut GVHD in hematologic malignancy patients?
Which gut microbiota biomarkers predict FMT response in aGVHD after allogeneic stem cell transplantation?
What are the adverse events associated with FMT in gut aGVHD and how are they managed?
Are there combination therapies with FMT for gut GVHD that enhance clinical outcomes in transplant recipients?
Trial Locations
- Locations (1)
中国
🇨🇳Suzhou, Jiangsu, China
中国🇨🇳Suzhou, Jiangsu, Chinaxiaofei qiContact051265223637qixiaofei@suda.edu.cn